News & Updates
Filter by Specialty:
Pemetrexed-based chemo boosts survival in NSCLC
15 Oct 2022
As an add-on to gefitinib monotherapy, pemetrexed-based chemotherapy improves survival outcomes in nonsmall cell lung cancer (NSCLC) patients harbouring EGFR mutations, a recent study has found.
Pemetrexed-based chemo boosts survival in NSCLC
15 Oct 2022Metformin, ivermectin, fluvoxamine OUT for severe COVID-19 prevention?
11 Oct 2022
byRoshini Claire Anthony
The use of metformin, fluvoxamine, or ivermectin in an outpatient setting did not appear to prevent progression to severe COVID-19, according to results of the phase III COVID-OUT trial.